Leading pharmaceutical labelling solutions backed by global resources
UPM Raflatac is exhibiting at Pharmapack 2014 in Paris, France 12-13 February. A team of pharmaceutical labelling experts will be present to discuss products fulfilling a wide variety of needs in pharmaceutical and healthcare labelling.
One of UPM Raflatac’s key innovations featuring at Pharmapack is the migration-safe RP 31 Purus adhesive specially developed for labelling liquid-filled containers made from non-glass materials such as LDPE. This high performance adhesive meets and exceeds all requirements in medical, pharmaceutical and healthcare applications where the risk of migration must be minimised. It is also a safe choice for labelling on small diameters.
RP 31 Purus complies with the demands of the Code of Federal Regulations, Food and Drugs Administration (FDA), 21 CFR Ch. I (April 1, 2011 edition) 175.105, and meets European Food contact regulations based on Food Framework Regulation 1935/2004. RP 31 Purus is also covered by a global change management processes which includes a minimum 12 months’ notice to qualify new materials, a last-call option to allow bulk purchasing before production discontinuation, and a minimum of 36 months’ rolling availability.
Visitors to Pharmapack are invited to find out more about UPM Raflatac’s pharmaceutical product range – dedicated paper and film label faces, and adhesives with properties such as high cohesion for small-diameter labelling, luminescence for missing label detection, and resistance to sterilization. Options for integrated security and anti-counterfeiting features are available to protect patient and consumer safety, traceability and brand equity. All UPM Raflatac products are backed by one-to-one customer service on the local level and the technical and R&D resources of a global leader in self-adhesive labelling.